Maria Cecilia Dignani, MD

Articles by Maria Cecilia Dignani, MD

Interexpert Agreement on Adverse Events’ Evaluation

ByMaxim Belotserkovskiy, MD,Maxim Kosov, MD, PhD,Alexey Maximovich,Maria Cecilia Dignani, MD,John Riefler, MD,Eric Batson MD, PhD

August 1st 2016

Applied Clinical Trials

Study measures the differing judgment levels between clinical investigators and drug safety experts.

Interexpert Agreement on Adverse Events’ Evaluation

ByMaxim Belotserkovskiy, MD,Maxim Kosov, MD, PhD,Alexey Maximovich,Maria Cecilia Dignani, MD,John Riefler, MD,Eric Batson MD, PhD

April 21st 2016

Drug safety surveillance, a core focus of clinical trials, can be influenced by subjective judgement, as this analysis of differing expert assessments of adverse drug reactions-and the reasons why-shows.

Latest Updated Articles

Interexpert Agreement on Adverse Events’ Evaluation
April 21st 2016
Interexpert Agreement on Adverse Events’ Evaluation
August 1st 2016

Maria Cecilia Dignani, MD

Articles by Maria Cecilia Dignani, MD

Interexpert Agreement on Adverse Events’ Evaluation

Interexpert Agreement on Adverse Events’ Evaluation

Latest Updated Articles

Trending on Applied Clinical Trials Online

When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny

Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It

How AI Is Changing Endpoint Selection Before a Trial Even Starts

How to recruit specialty volunteer populations for early-phase clinical research: 5 things to ask when choosing a CRO partner

Trust, Technology, and the Patient-Site Relationship: Q&A with Andrea Valente, uMotif